Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Excellion Innovations is a biotechnology company specializing in regenerative medicine and tissue engineering, based in Hyderabad, India. The company focuses on developing advanced wound care solutions, particularly for chronic and non-healing wounds such as diabetic foot ulcers and severe burns. Their flagship product, Excellion, is a proprietary acellular dermal matrix that serves as a scaffold to facilitate skin regeneration and tissue repair. By integrating biomaterials with cell-based therapy research, the company aims to provide affordable and effective treatments for complex dermatological conditions. Excellion Innovations operates with support from national research bodies and maintains a focus on translating laboratory innovations into clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S Excellion Innovations.